BioGenes and FyoniBio Combine Their Scientific Expertise and Cooperate on Pharmacokinetic and Immunogenicity Analyses.
FyoniBio and BioGenes have entered a new collaboration to streamline pharmacokinetic and immunogenicity projects for biopharma clients. By combining BioGenes’ antibody development and ELISA expertise with FyoniBio’s capabilities in GCLP-compliant bioassays and clinical sample analysis, the two Berlin-based companies now offer a seamless, full-service workflow — from early assay setup to validated clinical analysis. The first joint projects are already in preparation.
